Trial Profile
Effects of Arzoxifene on Bone Mineral Density in Korean Postmenopausal Women With Osteoporosis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Arzoxifene (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 18 Dec 2009 Actual patient number (91) added as reported by ClinicalTrials.gov.
- 18 Dec 2009 Actual end date (October 2009) added as reported by ClinicalTrials.gov.
- 18 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.